特刊：尿毒症中的免疫功能障碍。
Special Issue: Immune Dysfunction in Uremia.
机构信息
Department of Nephrology and Dialysis, Medical University of Vienna, A-1090 Vienna, Austria.
Nephrology Section, Department of Internal Medicine and Pediatrics, University Hospital Ghent, Corneel Heymanslaan, 10, B9000 Gent, Belgium.
出版信息
Toxins (Basel). 2021 Jan 19;13(1):70. doi: 10.3390/toxins13010070.
Abstract
This Special Issue of focusses on the interconnected factors interfering with the immune response in uremic patients [...].
摘要
本期特刊聚焦于干扰尿毒症患者免疫反应的相互关联因素[... ]。
相似文献
1
Special Issue: Immune Dysfunction in Uremia.特刊：尿毒症中的免疫功能障碍。
Toxins (Basel). 2021 Jan 19;13(1):70. doi: 10.3390/toxins13010070.
2
Immune Dysfunction in Uremia 2020.尿毒症中的免疫功能障碍 2020 年
Toxins (Basel). 2020 Jul 5;12(7):439. doi: 10.3390/toxins12070439.
3
Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.肠道衍生代谢物及其在慢性肾脏病免疫功能障碍中的作用。
Toxins (Basel). 2020 Apr 11;12(4):245. doi: 10.3390/toxins12040245.
4
Uremic Toxins and Cardiovascular System.尿毒症毒素与心血管系统
Cardiol Clin. 2021 Aug;39(3):307-318. doi: 10.1016/j.ccl.2021.04.002.
5
Immune dysfunction in uremia—an update.尿毒症中的免疫功能障碍——最新进展。
Toxins (Basel). 2012 Oct 24;4(11):962-90. doi: 10.3390/toxins4110962.
6
Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.肠道微生物群产生的尿毒症毒素对骨骼的影响：慢性肾脏病概述
Ther Apher Dial. 2015 Oct;19(5):436-40. doi: 10.1111/1744-9987.12307. Epub 2015 May 5.
7
Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?尿毒症患者的免疫低反应性是重症新型冠状病毒肺炎的保护因素吗？
Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):223-224. doi: 10.1016/j.nefro.2020.05.002. Epub 2020 May 23.
8
Monocytes in Uremia.尿毒症中的单核细胞。
Toxins (Basel). 2020 May 21;12(5):340. doi: 10.3390/toxins12050340.
9
Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.蛋白结合型尿毒症毒素、炎症和氧化应激：3-4 期慢性肾脏病的横断面研究。
Arch Med Res. 2014 May;45(4):309-17. doi: 10.1016/j.arcmed.2014.04.002. Epub 2014 Apr 18.
10
The Impact of CKD on Uremic Toxins and Gut Microbiota.慢性肾脏病对尿毒症毒素和肠道微生物群的影响。
Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252.
引用本文的文献
1
Development of a convenient and rapid screening zebrafish model to investigate lethal effects and immunocompromised states of uremic toxins.开发一种便捷快速的斑马鱼筛选模型，以研究尿毒症毒素的致死效应和免疫功能低下状态。
Ren Fail. 2025 Dec;47(1):2514183. doi: 10.1080/0886022X.2025.2514183. Epub 2025 Jun 8.
2
Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease.转移负担：慢性肾脏病中蛋白结合尿毒症毒素清除策略综述
J Clin Med. 2024 Mar 1;13(5):1428. doi: 10.3390/jcm13051428.
3
Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study.维持性血液透析中含柠檬酸盐浓缩物的免疫表型特征：一项前后对照研究。
Int J Nephrol. 2023 Sep 27;2023:7772677. doi: 10.1155/2023/7772677. eCollection 2023.
4
Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis.全免疫炎症值与腹膜透析患者的不良预后相关。
Ren Fail. 2023 Dec;45(1):2158103. doi: 10.1080/0886022X.2022.2158103.
5
COVID-19 Vaccination in Kidney Transplant Candidates and Recipients.肾移植候选者和接受者中的新冠病毒疫苗接种
Vaccines (Basel). 2022 Oct 27;10(11):1808. doi: 10.3390/vaccines10111808.
本文引用的文献
1
Immune Dysfunction in Uremia 2020.尿毒症中的免疫功能障碍 2020 年
Toxins (Basel). 2020 Jul 5;12(7):439. doi: 10.3390/toxins12070439.
2
Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.慢性肾脏病中的内皮损伤、炎症与免疫
Toxins (Basel). 2020 Jun 1;12(6):361. doi: 10.3390/toxins12060361.
3
Monocytes in Uremia.尿毒症中的单核细胞。
Toxins (Basel). 2020 May 21;12(5):340. doi: 10.3390/toxins12050340.
4
A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).比较使用中截留分子量膜（Theranova）和高通量膜（Revaclear）进行血液透析时万古霉素清除率的药代动力学研究。
Toxins (Basel). 2020 May 12;12(5):317. doi: 10.3390/toxins12050317.
5
Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells.慢性肾脏病相关免疫功能紊乱：蛋白结合型尿毒症潴留溶质对免疫细胞的影响。
Toxins (Basel). 2020 May 6;12(5):300. doi: 10.3390/toxins12050300.
6
Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.肠道衍生代谢物及其在慢性肾脏病免疫功能障碍中的作用。
Toxins (Basel). 2020 Apr 11;12(4):245. doi: 10.3390/toxins12040245.
7
Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses.尿毒症相关的胸腺衰老和适应性免疫反应。
Toxins (Basel). 2020 Apr 3;12(4):224. doi: 10.3390/toxins12040224.
8
Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ß but IL-6 and IL-10 Activation in Haemodialysis Patients.高容量血症诱导的免疫紊乱不涉及白细胞介素-1β，而涉及血液透析患者中白细胞介素-6 和白细胞介素-10 的激活。
Toxins (Basel). 2020 Mar 3;12(3):159. doi: 10.3390/toxins12030159.
9
Association of , and Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients.与氧化应激生物标志物及终末期肾病患者生存的关联研究。
Toxins (Basel). 2019 Jul 23;11(7):431. doi: 10.3390/toxins11070431.
10
Markers of Oxidative Stress and Endothelial Dysfunction Predict Haemodialysis Patients Survival.氧化应激和内皮功能障碍标志物可预测血液透析患者的生存。
Am J Nephrol. 2019;50(2):115-125. doi: 10.1159/000501300. Epub 2019 Jun 25.
Zotero 插件